iA Global Asset Management Inc.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1969566
Quebec, A8
Position in ALNY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,326,123
+$58,011 QoQ
Shares Held
17,693
+11.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#238
of 784 holders
Holding Since
Sep 2025
4 quarters on record
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026iA Global Asset Management Inc. holds $65,869,964 across 14 Biotechnology names. ALNY ranks #7 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,054 | $14,928,723 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,154 | $12,566,825 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
122,812 | $6,754,660 | |
| 4 | LEGN |
Legend Biotech Corp
|
211,135 | $6,097,578 | |
| 5 | ARGX |
Argenx SE
|
5,960 | $5,529,509 | |
| 6 | ZBIO |
Zenas BioPharma, Inc.
|
215,130 | $5,459,999 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
17,693 | $5,326,123 | |
| 8 | IRON |
Disc Medicine, Inc.
|
66,023 | $4,828,922 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,326,123 | 17,693 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $5,268,112 | 15,922 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $7,070,217 | 17,780 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $751,032 | 1,647 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||